Global Infectious Disease Point-of-Care Testing Market (2025-2031) | Share, Revenue, Analysis, Trends, Value, Companies, Growth, Forecast, Industry, Outlook, Size

Infectious Disease Point-Of-Care Testing Market Highlights

Report Name	Infectious Disease Point-Of-Care Testing Market
Forecast period	2025-2031
CAGR	7.8%
Growing Sector	Infectious Disease Point-Of-Care Testing

Topics Covered in the Infectious Disease Point-of-Care Testing Market Report

The Infectious Disease Point-of-Care Testing Market report thoroughly covers the market by Applications, Technologies, End-users and Regions. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.

Infectious Disease Point-of-Care Testing Devices Market Size & Analysis

Infectious Disease Point-of-Care Testing Market size is expected to see tremendous growth in the period between 2025 and 2031, with the market's approximate value expected to reach around USD 5.6 billion by 2031. This is anticipated to be fueled by increasing demands for point-of-care and easy-to-use testing devices, leading the market to see a strong compound annual growth rate (CAGR) of around 7.8% during the period 2025-2031.

Infectious Disease Point-of-Care Testing Market Synopsis

Infectious Disease Point-of-Care Testing Market is experiencing rapid growth because health systems globally are increasingly giving value to quick diagnostic devices. As increasing numbers of people are getting sensitized to the importance of early diagnosis in defeating infectious diseases, such devices are taking priority in healthcare centres all across the globe. The Infectious Disease Point-of-Care Testing Market is also witnessing unprecedented growth in portable, easy-to-use devices, which enable medical professionals to efficiently perform tests at or near the point of patient care.

According to 6Wresearch, the Infectious Disease Point-of-Care Testing Market is expected to grow at a CAGR of 7.8% during the forecast period 2025-2031. The increasing growth of the Infectious Disease Point-of-Care Testing Market is boosted by many underlying factors. Improvements in technology, e.g., the inculcation of AI and machine learning in medical testing equipment, have greatly contributed towards the reliability and speed of point-of-care testing. In addition, the increasing awareness of early disease detection and control has led to greater use of these appliances in different healthcare units. Increased rates of infectious diseases, as well as greater access to healthcare in developing countries, also fuel the growth of the market.

However, the industry is faced with serious challenges that can restrain its growth. High initial expenses of sophisticated diagnostic equipment and stringent regulation can be stumbling blocks for manufacturers. Once more, the poor infrastructure in rural and distant places is a stumbling block to the invasion of such technology. Despite all these issues, the Infectious Disease Point-of-Care Testing Market is proliferating, fuelled by increased investments in R&D and the need to enhance global health outcomes.

Infectious Disease Point-of-Care Testing Market Trends

The Infectious Disease Point-of-Care Testing Market is changing with several key trends defining its direction:

Ease of use and portability of diagnostic devices are propelling Infectious Disease Point-of-Care Testing Market Growth, particularly in resource-poor and remote settings.

Increased use of advanced technologies like IoT and AI is making point-of-care devices more accurate and effective.

Expansion of healthcare infrastructure in emerging markets is driving the Infectious Disease Point-of-Care Testing Market.

Opportunities for Investment in the Infectious Disease Point-of-Care Testing Market

Infectious Disease Point-of-Care Testing Market is growing at a fast pace with several profitable investment opportunities. As technology continues to develop and grow worldwide demand for a successful diagnosis, this market has enormous growth potential. The major opportunities are:

• Technological Innovation: Investment in Artificial Intelligence, IoT, and miniaturized diagnostics increases device efficiency and market demand.
• Emerging Markets Growth: The development of healthcare infrastructure across developing nations is driving emerging markets.
• Strategic Partnerships: Public-private alliances with healthcare public health groups and private sector producers can catalyse market coverage and supply.
• Rapid Diagnostics Demand: Increasing pandemic- and epidemic-spurred needs for rapid and successful testing are propelling recurring growth in markets.
• Government Support: Rising levels of healthcare spending and initiatives internationally promote recurring expansion and innovation.

Leading Players in the Infectious Disease Point-of-Care Testing Market

Infectious Disease Point-of-Care Testing Market is greatly influenced by key players who are developing technology and getting it to the world. Some of the prominent companies are:

• Abbott Laboratories: Famed for its cutting-edge diagnostic technology, from portable to rapid-testing devices.
• Siemens Healthineers: Provides a portfolio of next-generation, reliable testing systems for infectious diseases.
• Roche Diagnostics: Experts in developing innovative point-of-care technologies to simplify diagnostics.
• bioMérieux: Pioneer in molecular and immunoassay testing to provide fast results in healthcare environments.
• Thermo Fisher Scientific: Market leader in flexible diagnostic instruments and high R&D investment.

Government Regulations Introduced in the Infectious Disease Point-of-Care Testing Devices Market

Government regulations have a considerable influence on the Infectious Disease Point-of-Care Testing Devices Industry. Organizations like the United States FDA and the European Medicines Agency (EMA) have stringent regulations on safety, precision, and quality before the approval of medical devices for sale. These regulations not only ensure public health but also encourage innovation by offering a systematic approach for manufacturers to adhere to. Moreover, international standards and certifications, like ISO 13485, promote homogeneity and consistency across markets worldwide. Government-sponsored healthcare systems in countries could also drive market expansion with financing and payment strategies encouraging access to high-end testing technology. Adherence to such policies will also be essential for manufacturers wanting broader coverage, seeing products gain steady and quality performance and addressing the ever-changing challenge of infectious disease diagnosis globally.

Future Insights of the Infectious Disease Point-of-Care Testing Market

The outlook for the Infectious Disease Point-of-Care Testing Market is positively driven by continuous development in diagnostic tools and rising demands for rapid and precise testing solutions. Growth is expected to come largely from emerging markets, with improved healthcare infrastructure and rising awareness of infectious disease control fueling adoption. Technological advancements in biosensors, molecular diagnostics, and analytical methods using artificial intelligence will continue to expand the uses of these appliances to deliver quicker and more precise results. Portable and simple-to-use devices to deploy in remote or limited-resource locations will also aid in supporting market penetration. In addition, the Infectious Disease Point-of-Care Testing Market is expected to grow exponentially with increasing rates of global outbreaks and private and public healthcare infrastructure investments.

Market Segmentation Analysis

The report offers a comprehensive study of the subsequent market segments and their leading categories.

Lateral Flow Technology to Dominate Market-By Technologies

Lateral flow technology is expected to dominate the Infectious Disease Point-of-Care Testing Market Share due to its simplicity, low cost, and versatility thereby being highly appropriate for point-of-care testing. Technology in lateral flow assays has improved the sensitivity and accuracy of such tests and they are capable of providing quick results for many infectious diseases, especially in low-resource settings.

Hospitals to Dominate Market-By End-users

Hospitals will be the market leaders by end-users, as they continue to be the main place for infectious disease diagnosis and treatment. Due to the ability to make use of specialized professionals and sophisticated facilities, hospitals are in a better position to make optimal use of point-of-care testing equipment and offer timely and accurate diagnoses on a large scale.

Asia Pacific to Dominate Market-By Regions

According to Ravi Bhandari, Research Head, 6Wresearch, the Asia Pacific region will most probably dominate the market due to its huge population base, rising health expenditure, and high incidence of many infectious diseases. Government initiatives supporting the growth of healthcare infrastructure and the rising deployment in the region of technologically advanced diagnostic equipment further entrench its dominance. 

Key Attractiveness of the Report

• 10 Years of Market Numbers.
• Historical Data Starting from 2021 to 2024.
• Base Year: 2024
• Forecast Data until 2031.
• Key Performance Indicators Impacting the Market.
• Major Upcoming Developments and Projects.

Key Highlights of the Report:

• Infectious Disease Point-of-care Testing Market Overview
• Infectious Disease Point-of-care Testing Market Outlook
• Infectious Disease Point-of-care Testing Market Forecast
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues & Volume for the Period 2021-2031
• Infectious Disease Point-of-care Testing Market Size and Infectious Disease Point-of-care Testing Market Forecast of Revenues & Volume, Until 2031
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues & Volume, By End-users, for the Period 2021-2031
• Market Size & Forecast of Infectious Disease Point-of-care Testing Market Revenues & Volume, By End-users, Until 2031
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, for the Period 2021-2031
• Market Size & Forecast of Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, Until 2031
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues & Volume, by Technology, for the Period 2021-2031
• Market Size & Forecast of Infectious Disease Point-of-care Testing Market Revenues & Volume, by Technology, Until 2031
• Historical Data of Infectious Disease Point-of-care Testing Market Revenues, By Regions, for the Period 2021-2031
• Market Size & Forecast of Infectious Disease Point-of-care Testing Market Revenues, By Regions, Until 2031
• Historical Data of Asia Pacific Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Asia Pacific Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of Latin America Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Latin America Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of Europe Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Europe Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of Middle East Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Middle East Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of North America Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of North America Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Historical Data of Africa Infectious Disease Point-of-care Testing Market Revenues, for the Period 2021-2031
• Market Size & Forecast of Africa Infectious Disease Point-of-care Testing Market Revenues, Until 2031
• Market Drivers and Restraints
• Infectious Disease Point-of-care Testing Market Trends and Industry Life Cycle
• Porter’s Five Force Analysis
• Market Opportunity Assessment
• Infectious Disease Point-of-care Testing Market Share, By Players
• Infectious Disease Point-of-care Testing Market Share, By Regions
• Infectious Disease Point-of-care Testing Market Overview on Competitive Benchmarking
• Company Profiles
• Key Strategic Recommendations

Markets Covered

The market report provides a detailed analysis of the following market segments:

By Applications:

• Tropical Disease
• Liver Disease
• Respiratory Disease
• Sexual Disorders
• Others

By Technologies:

• Lateral Flow
• Flow-through
• Agglutination Assays
• Solid Phase

By End-users:

• Diagnostic Laboratories
• Hospitals
• Home-care Settings
• Others

By Regions:

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East
• Africa